598 related articles for article (PubMed ID: 31571136)
1. Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design.
Sugrue DM; Ward T; Rai S; McEwan P; van Haalen HGM
Pharmacoeconomics; 2019 Dec; 37(12):1451-1468. PubMed ID: 31571136
[TBL] [Abstract][Full Text] [Related]
2. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
[TBL] [Abstract][Full Text] [Related]
3. A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease.
Schlackow I; Kent S; Herrington W; Emberson J; Haynes R; Reith C; Wanner C; Fellström B; Gray A; Landray MJ; Baigent C; Mihaylova B;
Heart; 2017 Dec; 103(23):1880-1890. PubMed ID: 28780579
[TBL] [Abstract][Full Text] [Related]
4. Fasting Urinary Osmolality, CKD Progression, and Mortality: A Prospective Observational Study.
Tabibzadeh N; Wagner S; Metzger M; Flamant M; Houillier P; Boffa JJ; Vrtovsnik F; Thervet E; Stengel B; Haymann JP;
Am J Kidney Dis; 2019 May; 73(5):596-604. PubMed ID: 30777634
[TBL] [Abstract][Full Text] [Related]
5. Modeling Chronic Kidney Disease in Type 2 Diabetes Mellitus: A Systematic Literature Review of Models, Data Sources, and Derivation Cohorts.
Pöhlmann J; Bergenheim K; Garcia Sanchez JJ; Rao N; Briggs A; Pollock RF
Diabetes Ther; 2022 Apr; 13(4):651-677. PubMed ID: 35290625
[TBL] [Abstract][Full Text] [Related]
6. Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea.
Go DS; Kim SH; Park J; Ryu DR; Lee HJ; Jo MW
Nephrology (Carlton); 2019 Jan; 24(1):56-64. PubMed ID: 29206319
[TBL] [Abstract][Full Text] [Related]
7. Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics.
Provenzano M; Chiodini P; Minutolo R; Zoccali C; Bellizzi V; Conte G; Locatelli F; Tripepi G; Del Vecchio L; Mallamaci F; Di Micco L; Russo D; Heerspink HJL; De Nicola L
Nephrol Dial Transplant; 2020 Jan; 35(1):138-147. PubMed ID: 30053127
[TBL] [Abstract][Full Text] [Related]
8. Long-term health outcomes of people with reduced kidney function in the UK: A modelling study using population health data.
Schlackow I; Simons C; Oke J; Feakins B; O'Callaghan CA; Hobbs FDR; Lasserson D; Stevens RJ; Perera R; Mihaylova B
PLoS Med; 2020 Dec; 17(12):e1003478. PubMed ID: 33326459
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of stage 1-5 chronic kidney disease in Mainland China.
Lai X; Zhang AH; Chen SY; He L; Su CY; Fan MH; Wang T
Ren Fail; 2014 May; 36(4):520-5. PubMed ID: 24456114
[TBL] [Abstract][Full Text] [Related]
10. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
[TBL] [Abstract][Full Text] [Related]
11. Improved survival and renal prognosis of patients with type 2 diabetes and nephropathy with improved control of risk factors.
Andrésdóttir G; Jensen ML; Carstensen B; Parving HH; Rossing K; Hansen TW; Rossing P
Diabetes Care; 2014 Jun; 37(6):1660-7. PubMed ID: 24623028
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease.
Agarwal R; Duffin KL; Laska DA; Voelker JR; Breyer MD; Mitchell PG
Nephrol Dial Transplant; 2014 Dec; 29(12):2293-302. PubMed ID: 25085239
[TBL] [Abstract][Full Text] [Related]
13. A contemporary evaluation of carotid endarterectomy outcomes in patients with chronic kidney disease in the United States.
Patel AR; Dombrovskiy VY; Vogel TR
Vascular; 2017 Oct; 25(5):459-465. PubMed ID: 28181855
[TBL] [Abstract][Full Text] [Related]
14. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
[TBL] [Abstract][Full Text] [Related]
15. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Grams ME; Yang W; Rebholz CM; Wang X; Porter AC; Inker LA; Horwitz E; Sondheimer JH; Hamm LL; He J; Weir MR; Jaar BG; Shafi T; Appel LJ; Hsu CY;
Am J Kidney Dis; 2017 Sep; 70(3):337-346. PubMed ID: 28366517
[TBL] [Abstract][Full Text] [Related]
16. Risk Prediction for Early CKD in Type 2 Diabetes.
Dunkler D; Gao P; Lee SF; Heinze G; Clase CM; Tobe S; Teo KK; Gerstein H; Mann JF; Oberbauer R;
Clin J Am Soc Nephrol; 2015 Aug; 10(8):1371-9. PubMed ID: 26175542
[TBL] [Abstract][Full Text] [Related]
17. An economic analysis of captopril in the treatment of diabetic nephropathy. The Collaborative Study Group.
Rodby RA; Firth LM; Lewis EJ
Diabetes Care; 1996 Oct; 19(10):1051-61. PubMed ID: 8886549
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of proteinuria and glomerular filtration rate on Taiwanese patients with diabetes mellitus and advanced chronic kidney disease: a single center experience.
Chen PM; Wada T; Chiang CK
Clin Exp Nephrol; 2017 Apr; 21(2):307-315. PubMed ID: 27339442
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
